{
    "SPADE_UN_15302": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15302",
            "Peptide Name": "CIGB-300 (P15-Tat)",
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "CWMSPRHLGTCGRKKRRQRRRPPQ",
            "Sequence Length": 24,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:SiHa (IC50=135±10 µmol/L); HeLa (IC50=136±16  µmol/L); 3LL (IC50=143±4 µmol/L); A549 (IC50=171±12 µmol/L); Ca Ski (IC50=182±6  µmol/L); NCI-H82 (IC50=20±3 µmol/L); PC-3 (IC50=201±16 µmol/L); HL-60 (IC50=30±3 µmol/L); NCI-H125 (IC50=36±9  µmol/L); TC-1 (IC50=71±15  µmol/L); Jurkat (IC50=89±3  µmol/L)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Not available",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C124H212N52O29S3",
            "Mass": 2991.54,
            "PI": 12.0,
            "Net Charge": 10,
            "Hydrophobicity": -1.95,
            "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "CIGB-300 is a cyclic synthetic peptide that induces apoptosis in malignant cells, elicits antitumor activity in cancer animal models",
            "Literature": [
                {
                    "Title": "Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)",
                    "Pubmed ID": "15466209",
                    "Reference": "Cancer Res. 2004 Oct 1;64(19)7127-9.",
                    "Author": "Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, López E, Falcón V, Alonso DF.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15466209"
                }
            ],
            "Frequent Amino Acids": "RPC",
            "Absent Amino Acids": "ADEFINOUVY",
            "Basic Residues": 10,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 16,
            "Positive Residues": 10,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07310",
                    "Similarity": 1.0,
                    "Sequence": "CGRKKRRQRRRPPQ"
                },
                {
                    "SPADE_ID": "SPADE_N_05069",
                    "Similarity": 1.0,
                    "Sequence": "GRKKRRQRRRPPQ"
                },
                {
                    "SPADE_ID": "SPADE_N_06889",
                    "Similarity": 1.0,
                    "Sequence": "GRKKRRQRRRPP"
                }
            ]
        }
    }
}